港股收評:恒指微跌0.08%,科技股分化,創新藥午後升幅加大,券商股拉昇轉升
港股三大指數整體呈現窄幅震盪行情,尾盤短線跳水,恒生指數、國企指數分別微幅下跌0.08%及0.09%,恒生科技指數表現相對較強最終收升0.56%。盤面上,大型科技股升跌不一,美團升超1%,網易、騰訊飄紅,百度跌超3%,小米跌2%,阿里巴巴跌超1%;生物醫藥股大肆走高,創新藥午後升幅進一步擴大,康諾亞大升14.5%,康方生物、百濟神州升超10%,泰格醫藥、金斯瑞生物科技、科倫博泰生物升超8%;半導體芯片股、軍工股、汽車股、蘋果概念股、腦機接口概念股、餐飲股多數表現活躍,早盤低迷的中資券商股午後曾異動拉昇轉升,中信建投、中金公司升幅居前。另一方面,“解僱鮑威爾”風波暫緩,金價有所回落,黃金股呈現單邊下跌行情,銅等有色金屬股齊跌,稀土概念股亦走低,航空股、海運股、石油股、濠賭股、石油股、煤炭股紛紛表現弱勢。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.